Patent ID: 11963991
Assignee: NIELSEN BIOSCIENCES, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A pharmaceutical composition having a cumulative dose of between 0.5 to 10 units of potency comprising a sterile filtered extract of two or more strains of Candida albicans and secreted antigens and a pharmaceutically acceptable diluent, wherein each of the two or more strains of Candida albicans is selected from the group consisting of a strain having been deposited with the American Type Culture Collection (ATCC) under ATCC Accession No. PTA-126019, a strain having been deposited under ATCC Accession No. PTA-126020, and a strain having been deposited under ATCC Accession No. ATCC-10231, and wherein the pharmaceutical composition is effective for partial or complete resolution of one or more warts.